Summary
The varicella-zoster virus causes both chickenpox and shingles. Vaccines are available to prevent both the initial chickenpox infection and the later reactivation of the virus as shingles.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The varicella-zoster virus (VZV) is responsible for primary infection as chickenpox.
- VZV can reactivate decades later, causing the painful condition known as shingles.
Purpose of the Study:
- To inform about the dual nature of VZV infections.
- To highlight the availability of preventative vaccines for both chickenpox and shingles.
Main Methods:
- Review of VZV pathogenesis.
- Summary of vaccine efficacy data.
Main Results:
- VZV causes distinct clinical syndromes: chickenpox and shingles.
- Vaccines effectively prevent primary VZV infection and subsequent reactivation.
Conclusions:
- Vaccination is a key strategy for preventing VZV-related diseases.
- Public health initiatives should promote VZV vaccination for comprehensive disease control.
More Related Videos
Related Concept Videos
01:17Sleepwalking and Sleep Talking
1.0K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.0K
01:13Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
01:15Drug Dosing: Geriatric Patients
274
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
274
01:21Drug Dosing: Obese Patients
265
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
265
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
238
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
238
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
264
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264